Separation of recombinant human vasoactive intestinal peptide-humanin fusion protein via three different approaches

Biochemical Engineering Journal

Volumn 41, Issue 2, 2008, Pages 116-121

  Chang, Jing ^a   Chen, Jinchun ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Bioseparations; Protein denaturation; Protein recovery; Recombinant DNA; Refolding; Vasoactive intestinal peptide

Indexed keywords

AMINES; ESCHERICHIA COLI; FUSION REACTIONS; HEALTH; PEPTIDES; SEPARATION;

ALZHEIMER'S DISEASE (AD); CO-EXPRESSION; FUSION PROTEINS; HISTIDINE (HIS); HUMANIN (HN); INCLUSION BODIES; NEUROPROTECTION; VASOACTIVE INTESTINAL PEPTIDE (VIP);

NUCLEAR PHYSICS;

HUMANIN; HYBRID PROTEIN; RECOMBINANT DNA; RECOMBINANT PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL INCLUSION; CHROMATOGRAPHY; ESCHERICHIA COLI; GENE CONSTRUCT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN RENATURATION;

ESCHERICHIA COLI;

EID: 47849099589     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2008.04.004     Document Type: Article

References (15)

1. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262 (1989) 2551-2556
2. Glenner G.G. Alzheimer's disease: its proteins and genes. Cell 52 (1988) 307-308
3. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
4. Yankner B.A. Mechanism of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996) 921-932
5. Gozes I., Shani Y., and Rostene W.H. Developmental expression of the VIP-gene in brain and intestine. Mol. Brain Res. 2 (1987) 137-148
6. Jegou S., Javoy-Agid F., Delbende C., Tranchand-Bunel D., Coy D.H., Agid Y., and Vaudry H. Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects. Peptides 9 (1988) 787-793
7. Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D.E., and Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res. 854 (2000) 257-262
8. Hashimoto Y., Niikura T., Ito Y., Sudo H., Hata M., and Arakawa E. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease relevant insults. J. Neurosci. 21 (2001) 9235-9245
9. Nishimoto I., Matsuoka M., and Niikura T. Unravelling the role of humanin. Trends Mol. Med. 10 (2004) 102-105
10. Rogl H., Kosemund K., and Kuhlbrandt Collinson W. Refolding of Escherichia coli produced membrane protein inclusion bodies immobilized by nickel chelating chromatography. FEBS Lett. 432 (1998) 21-26
11. Schagger H., and von Jagow G. Tricine-sodium dodecylsulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
12. Fischer B., Sumner I., and Goodenough P. Isolation and renaturation of bioactive proteins expressed in Escherichia coli as inclusion bodies. Arzneimittelforschung 42 (1992) 1512-1515
13. Datar R.V., Cartwright T., and Rosén C.G. Process economics of animal cell and bacterial fermentations: a case study analysis of tissue plasminogen activator. Bio/Technology 11 (1993) 349-357
14. Hevehan D.L., and Clark E.B. Oxidative renaturation of lysozyme at high concentrations. Biotechnol. Bioeng. 54 (1997) 221-230
15. Katoh S., and Katoh Y. Continuous refolding of lysozyme with fedbatch addition of denatured protein solution. Process Biochem. 35 (2000) 1119-1124